* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Basic Epidemiologic Concepts
Survey
Document related concepts
Transcript
Community Medicine V Dr. Mehrdad Askarian MD, MPH Professor of Community Medicine Atherosclerosis & Hypertension Atherosclerosis • Introduction – Most common cause of death in most countries – One third of MI patients die (half of them during the 1st hr of MI and before hospitalization) Atherosclerosis • Prevalence – 12 million death/yr in the world. – Half of deaths in all developed and developing countries. – Early mortality rate of males is 2 times of women. – In women, sign and symptoms appear 10 years later than males. Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • Cigarette smoking Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • Cigarette smoking • High LDL Cholesterol Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • Cigarette smoking • High LDL Cholesterol • High fat and Cholesterol diet Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • • • • Cigarette smoking High LDL Cholesterol High fat and Cholesterol diet Hypertension (HTN) Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • • • • • Cigarette smoking High LDL Cholesterol High fat and Cholesterol diet Hypertension (HTN) Left Ventricular Hypertrophy (LVH) Atherosclerosis • Risk factors – Group 1: their modification causes lowering risk of disease acquisition • • • • • • Cigarette smoking High LDL Cholesterol High fat and Cholesterol diet Hypertension (HTN) Left Ventricular Hypertrophy (LVH) Hypercoagulable state (high blood fibrinogen level) Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • Diabetes Mellitus Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • Diabetes Mellitus • Immobilization Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • Diabetes Mellitus • Immobilization • Low HDL Cholesterol Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • • • • Diabetes Mellitus Immobilization Low HDL Cholesterol High Triglyceride, high LDL Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • • • • • Diabetes Mellitus Immobilization Low HDL Cholesterol High Triglyceride, high LDL Obesity Atherosclerosis • Risk factors – Group 2: their modification is most probable to lower risk of disease acquisition • • • • • • Diabetes Mellitus Immobilization Low HDL Cholesterol High Triglyceride, high LDL Obesity Menopause Atherosclerosis • Risk factors – Group 3: their modification may cause lowering risk of disease acquisition • Psychosocial factors Atherosclerosis • Risk factors – Group 3: their modification may cause lowering risk of disease acquisition • Psychosocial factors • High levels of blood lipoprotein (a) Atherosclerosis • Risk factors – Group 3: their modification may cause lowering risk of disease acquisition • • • • Psychosocial factors High levels of blood lipoprotein (a) High levels of homocysteine No alcohol consumption Atherosclerosis • Risk factors – Group 4: their modification is not possible, lowering risk of disease acquisition • Age > 45y/o in males and >55 y/o in females Atherosclerosis • Risk factors – Group 4: their modification doesn’t cause lowering risk of disease acquisition • Age > 45y/o in males and >55 y/o in females • Male gender Atherosclerosis • Risk factors – Group 4: their modification doesn’t cause lowering risk of disease acquisition • Age > 45y/o in males and >55 y/o in females • Male gender • Low socioeconomic class Atherosclerosis • Risk factors – Group 4: their modification doesn’t cause lowering risk of disease acquisition • • • • Age > 45y/o in males and >55 y/o in females Male gender Low socioeconomic class Family history of early onset coronary artery disease Cholesterol • Blood cholesterol level more than 160mg/dl has a strong correlation with CAD and death rate due to it and other causes of mortality, totally. • High saturated TG intake in presence of normal blood level of cholesterol is associated with high prevalence of CAD. • Each 1% decrease of cholesterol can cause 2-5% decrease risk of CAD. Cholesterol • In Iran – Total cholesterol in 41% of males and 47% of females was 200 mg/dl or higher. – Hypertriglyceridemia in 32% of population – High LDL (>130 mg/dl) in 51% – Low HDL (<35 mg/dl) levels in 6% of population. Cigarette smoking • The most important factor to cause early death in 35-69 y/o people in developed countries. (cause of 30% of deaths in this age group. • About 50% increase in mortality rate due to CAD. • Each 10 increases 18% mortality in males and 31% in females. • 37% of nonsmokers are passive smokers which increases CAD by 30% in this group. Cigarette smoking • In Iran: – 27% of males in age groups of 15-69 y/o – 3% of females in age groups of 15-69 y/o, smoke. – 66% of respondents started smoking around 15-24 y/o. – Cost of smoking in Iran estimated to be 9.2 milliard Rials annually. Hypertension • Strong positive linear correlation between level of systolic and diastolic blood pressure and CAD exists, in presence of normal levels of blood pressure. • With controlling of blood pressure levels, we can prevent CAD, CVA and CHF. Diabetes mellitus • Important risk factor for atherosclerosis (both IDDM and NIDDM). • Atherosclerosis is the leading cause of mortality in 80% of diabetic patients. • IDDM increases risk of mortality due to CAD by 300%. • Death rates increases due to cardiovascular diseases in NIDDM males by 2 and females by 4 times. Obesity • BMI≥27 is indicative of obesity • Risk factors of obesity is related to degree of obesity and fat distribution. • Abdominal obesity less than 0.9 in males and less than 0.8 in women is suggested. • Obesity increases risk of CAD by 2 times in males and by 2.5 times in females. • Obesity has been detected in 36% of males and 52% of females inTehran. Low Physical Activity • Increases risk of CAD by 2 times. • 80% of males and 85% of females in Tehran did not reported any physical activity except than their job. Prevention of CVD • Smoking cessation • Low fat diet and healthy diet from 2 y/o on. – In which total fat intake per day should not be exceeds to 20% of calorie intake. – Decrease saturated fat to 8-10% of daily fat intake. – And decrease cholesterol intake to less than 300 mg/day. • Decrease salt intake (NaCl) Prevention of CVD • Increase fresh fruit and vegetables to 5 times a day. • Increase physical activity to 30 minutes/day as an average intensity, 3 times a week. • 21<BMI<25 • Measuring Blood pressure levels every other years (at least) • Measuring cholesterol levels and HDL every 5 years for those with the age of 20 or more. Hypertension • Levels of blood pressure in which patient has increased risk of mortality and morbidity. (Systolic BP ≥ 140 mmHg and diastolic BP of ≥90 mmHg). • Is one of the major causes of CAD and CVD • Most common cause of renal failure • Law of halves Hypertension • High risk groups – Blacks > Whites (prevalence and complications) – females < males (before 55 y/o) (lower complications) – BP level is inversely related to level of education and economic status. Hypertension • In Iran: – Diastolic HTN in more than 14% of 12-69 y/o population. – Diastolic HTN in more than 34% of 35-69 y/o population. Hypertension • Prevention and control – Primary prevention & Secondary prevention • Healthy diet, low salt, low saturated fat and cholesterol • Increase intake of fresh vegetables and fruits • Appropriate calorie intake and prevention of obesity. • Increase activity to 3 days in a week and 30 minutes for each time. • Avoiding Cigarette smoking • BP<140/90 and <130/85 in diabetics Lipids Modification • In persons without risk factor or one risk factor, except for DM, LDL: 130-159. • In persons with 2 risk factors except for DM and probability of CAD during next 10 yrs lower than 20% , LDL<130 mg/dL • In persons with DM and probability of CAD during next 10 yrs greater than 20% , LDL<100 mg/dL. Hypertension • Limitations for controlling of Hypertension – Not to follow physician’s orders • Communication problems • Psycho-behavioral problems • Side effects of drugs Hypertension • Limitations for controlling of Hypertension – Not to follow physician’s orders • Communication problems • Psycho-behavioral problems • Side effects of drugs • Limited knowledge of physicians regarding importance of BP control. Hypertension • Inadequate response to drug prescription Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension – Drug interaction Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension – Drug interaction • Associated disorders Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension – Drug interaction • Associated disorders – Renal failure Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension – Drug interaction • Associated disorders – Renal failure – obesity Hypertension • Inadequate response to drug prescription – Inappropriate prescription of drug – Secondary hypertension – Drug interaction • Associated disorders – Renal failure – obesity • Economical limitations Hypertension • Recommendations for controlling hypertension in Iran: – To increase knowledge of physicians and all other HCWs with the disease and its complications. – To increase knowledge of physicians regarding new treatments and objectives of treatment. – To aware population regarding the disease and its complications – Calculating the rate of hypertension in different groups of population – To create centers for screening and offering treatments and guidance of patients. Any Comments or Questions?